OTLK earnings: a positive outcome, +5.9%

On December 29, 2022, Outlook Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +5.9% in the window around the event. It had already run +5.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.